<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Pfizer on VitaminDWiki</title><link>/tags/pfizer.html</link><description>Recent content in Pfizer on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Tue, 17 Feb 2015 00:00:00 +0000</lastBuildDate><atom:link href="/tags/pfizer/index.xml" rel="self" type="application/rss+xml"/><item><title>Antibiotic resistance will kill 300 million in 35 years, FDA doing nothing, UK considering wrong things</title><link>/posts/antibiotic-resistance-will-kill-300-million-in-35-years-fda-doing-nothing-uk-con-ng-wrong-things.html</link><pubDate>Tue, 17 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/antibiotic-resistance-will-kill-300-million-in-35-years-fda-doing-nothing-uk-con-ng-wrong-things.html</guid><description>&lt;h3 id="antibiotic-resistance-will-kill-300-million-people-by-2050httparticlesmercolacomsitesarticlesarchive20150217antibiotic-resistance-food-productionaspxe_cid20150217z1_dnl_nb_art_1utm_sourcednlutm_mediumemailutm_contentart1utm_campaign20150217z1_dnl_nbet_ciddm67823et_rid845041288-mercola-feb-2015">&lt;a href="http://articles.mercola.com/sites/articles/archive/2015/02/17/antibiotic-resistance-food-production.aspx?e_cid=20150217Z1_DNL_NB_art_1&amp;amp;utm_source=dnl&amp;amp;utm_medium=email&amp;amp;utm_content=art1&amp;amp;utm_campaign=20150217Z1_DNL_NB&amp;amp;et_cid=DM67823&amp;amp;et_rid=845041288">Antibiotic Resistance Will Kill 300 Million People by 2050&lt;/a> Mercola Feb 2015&lt;/h3>
&lt;p>&lt;strong>“There are some glimmers of hope though.&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Six of the largest school districts in the US recently decided to switch to antibiotic-free chicken in their cafeterias”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>UN Calls for End to Industrialized Farming&lt;/p>
&lt;/li>
&lt;li>
&lt;p>. . Organic farm fields yielded 33 % more in drought years compared with chemically managed ones.&lt;/p>
&lt;/li>
&lt;/ul>
&lt;h3 id="food-labels">Food labels&lt;/h3>
&lt;ol>
&lt;li>&lt;strong>100% USDA Organic&lt;/strong> label offers excellent assurance that antibiotics have not been used at any stage of production.&lt;/li>
&lt;/ol>
&lt;ul>
&lt;li>&amp;quot; &lt;strong>No antibiotics administered&lt;/strong> &amp;quot; and similar labels also offer high assurance that antibiotics have not been used, especially if accompanied by a &amp;ldquo;USDA process Verified&amp;rdquo; shield.&lt;/li>
&lt;/ul>
&lt;ol>
&lt;li>
&lt;p>&amp;quot; &lt;strong>Grass-fed&lt;/strong> &amp;quot; label coupled with USDA Organic label means no antibiotics have been used, but if the &amp;ldquo;grass-fed&amp;rdquo; label appears alone, antibiotics may have been given.&lt;/p></description></item><item><title>Falls are prevented by vitamin D - provided you get enough</title><link>/posts/falls-are-prevented-by-vitamin-d-provided-you-get-enough.html</link><pubDate>Thu, 11 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/falls-are-prevented-by-vitamin-d-provided-you-get-enough.html</guid><description>&lt;p> &lt;/p>
&lt;p>&lt;strong>Study, comment, reply to the comment, then VitaminDWiki references&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#differences-in-overlapping-meta-analyses-of-vitamin-d-supplements-and-falls">Differences in Overlapping Meta-Analyses of Vitamin D Supplements and Falls&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-falls-treat-the-deficiency-and-the-ones-at-risk">Vitamin D and Falls: Treat the Deficiency (and the Ones at Risk)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#response-to-amrein-et-al">Response to Amrein et al.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="differences-in-overlapping-meta-analyses-of-vitamin-d-supplements-and-falls">Differences in Overlapping Meta-Analyses of Vitamin D Supplements and Falls&lt;/h4>
&lt;p>Journal of Clinical Endocrinology and Metabolism, DOI: &lt;a href="http://dx.doi.org/10.1210/jc.2014-2562">http://dx.doi.org/10.1210/jc.2014-2562&lt;/a>&lt;/p>
&lt;p>Received: June 04, 2014, Published Online: August 05, 2014&lt;/p>
&lt;p>Mark J. Bolland, Andrew Grey, and Ian R. Reid&lt;/p></description></item><item><title>Off Topic:Largest employeer in most states is Health Care</title><link>/posts/off-topiclargest-employeer-in-most-states-is-health-care.html</link><pubDate>Sat, 02 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/off-topiclargest-employeer-in-most-states-is-health-care.html</guid><description>&lt;h3 id="from-httpdadavizcomi462httpdadavizcomi462">From &lt;a href="http://dadaviz.com/i/462">http://dadaviz.com/i/462&lt;/a>&lt;/h3>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/health-care-now-largest-employer.jpg" alt="image">
&lt;h3 id="from-httpdadavizcomi461httpdadavizcomi461">From &lt;a href="http://dadaviz.com/i/461">http://dadaviz.com/i/461&lt;/a>&lt;/h3>
&lt;p>&lt;strong>Sources of Health Care $ 1961&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/health-care-1961.jpg" alt="image">
&lt;p>&lt;strong>Sources of Health Care $ 2012&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/us-medical-bill-2012.jpg" alt="image">
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>&lt;a href="/posts/cost-of-us-health-exceeds-the-cost-of-food">Cost of US health exceeds the cost of food&lt;/a>&lt;/li>
&lt;/ul>
&lt;h2 id="see-also-web">See also web&lt;/h2>
&lt;ul>
&lt;li>&lt;a href="http://www.drugwatch.com/manufacturer/">Big Pharma&lt;/a> Drug watch&lt;/li>
&lt;/ul>
&lt;blockquote>
&lt;p>contributes heavily to the annual budget of the U.S. Food and Drug Administration (FDA),&lt;/p>
&lt;/blockquote>
&lt;blockquote>
&lt;p>1,100-plus paid lobbyists&lt;/p>
&lt;/blockquote>
&lt;blockquote>
&lt;p>From 1998 to 2013, Big Pharma spent nearly $2.7 billion on lobbying expenses&lt;/p>
&lt;/blockquote>
&lt;blockquote>
&lt;p>    42 % more than the second highest paying industry: insurance.&lt;/p></description></item><item><title>Institute of Medicine (which recommended low vitamin D) has many conflicts of interest</title><link>/posts/institute-of-medicine-which-recommended-low-vitamin-d-has-many-conflicts-of-interest.html</link><pubDate>Tue, 15 Jul 2014 00:00:00 +0000</pubDate><guid>/posts/institute-of-medicine-which-recommended-low-vitamin-d-has-many-conflicts-of-interest.html</guid><description>&lt;h4 id="premier-government-body-of-science-and-medicine-turning-into-yet-another-agency-for-corporate-sciencehttparticlesmercolacomsitesarticlesarchive20140715institute-medicine-zohydro-painkilleraspxe_cid20140715z1_dnl_art_1utm_sourcednlutm_mediumemailutm_contentart1utm_campaign20140715z1et_ciddm52780et_rid586456336-mercola-july-2014">&lt;a href="http://articles.mercola.com/sites/articles/archive/2014/07/15/institute-medicine-zohydro-painkiller.aspx?e_cid=20140715Z1_DNL_art_1&amp;amp;utm_source=dnl&amp;amp;utm_medium=email&amp;amp;utm_content=art1&amp;amp;utm_campaign=20140715Z1&amp;amp;et_cid=DM52780&amp;amp;et_rid=586456336">Premier Government Body of Science and Medicine Turning Into Yet Another Agency for Corporate Science&lt;/a> Mercola July 2014&lt;/h4>
&lt;p>&lt;strong>Snips – Pain panel&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>A Journal Sentinel/MedPage Today investigation found that nine of the 19 experts on the IOM panel that produced that report had connections to companies that manufacture narcotic painkillers at the time or in the three years prior to their work on the report.”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Indeed, six of the IOM panel members have been officers or board members of advocacy groups that were named in a 2012 U.S. Senate Committee on Finance investigation into the links. Details at &lt;a href="http://www.medpagetoday.com/PainManagement/PainManagement/46482">http://www.medpagetoday.com/PainManagement/PainManagement/46482&lt;/a>&lt;/p></description></item><item><title>Comparison of Alzheimer's Disease and Parkinson's Disease</title><link>/posts/comparison-of-alzheimers-disease-and-parkinsons-disease.html</link><pubDate>Fri, 27 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/comparison-of-alzheimers-disease-and-parkinsons-disease.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#comparing-clinical-profiles-in-alzheimers-disease-and-parkinsons-disease-dementia">Comparing Clinical Profiles in Alzheimer&amp;rsquo;s Disease and Parkinson&amp;rsquo;s Disease Dementia&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#materials-and-methods">Materials and Methods&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#clinical-studies">Clinical Studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#statistical-analysis">Statistical Analysis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#patients">Patients&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comparison-of-baseline-adas-cog-adcs-adl-and-npi-10-data-between-the-ad-and-pdd-patient-populations">Comparison of Baseline ADAS-cog, ADCS-ADL and NPI-10 Data between the AD and PDD Patient Populations&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#acknowledgements">Acknowledgements&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#disclosure-statement">Disclosure Statement&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h2 id="comparing-clinical-profiles-in-alzheimers-disease-and-parkinsons-disease-dementia">Comparing Clinical Profiles in Alzheimer&amp;rsquo;s Disease and Parkinson&amp;rsquo;s Disease Dementia&lt;/h2>
&lt;p>Dement Geriatr Cogn Disord Extra 2013;3:281-290 Sept 2013&lt;/p>
&lt;p>Martin R. Farlowa Frederick Schmitt b Dag Aarsland c d George T. Grossberg e Monique Somogyi f Xiangyi Mengf&lt;/p></description></item><item><title>Vascular calcification greatly reduced by 3 per week 1000 ug of Vitamin K2 MK-7</title><link>/posts/vascular-calcification-greatly-reduced-by-3-per-week-1000-ug-of-vitamin-k2-mk-7.html</link><pubDate>Sat, 21 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/vascular-calcification-greatly-reduced-by-3-per-week-1000-ug-of-vitamin-k2-mk-7.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#press-release-12192013-menaq7-vitamin-k2-supplementation-may-benefit-dialysis-patients-by-inhibiting-vascular-calcification">Press Release 12/19/2013: MenaQ7® Vitamin K2 Supplementation May Benefit Dialysis Patients by Inhibiting Vascular Calcification&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-k2-supplementation-in-haemodialysis-patients-a-randomized-dose-finding-study">Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study*&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="press-release-12192013-menaq7-vitamin-k2-supplementation-may-benefit-dialysis-patients-by-inhibiting-vascular-calcification">Press Release 12/19/2013: MenaQ7® Vitamin K2 Supplementation May Benefit Dialysis Patients by Inhibiting Vascular Calcification&lt;/h4>
&lt;p>NattoPharma has announced the publication of a new study performed in collaboration with OLV Hospital, Belgium, St. Jan Hospital, Belgium and VitaK, University of Maastricht, the Netherlands, published by Nephrology Dialysis Transplantation. &lt;a href="https://doi.org/10.1093/ndt/gft464">doi: 10.1093/ndt/gft464&lt;/a> .&lt;/p></description></item><item><title>Supplements - why and which</title><link>/posts/supplements-why-and-which.html</link><pubDate>Tue, 05 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/supplements-why-and-which.html</guid><description>&lt;h2 id="why-us-adults-use-dietary-supplements">Why US Adults Use Dietary Supplements&lt;/h2>
&lt;p>JAMA Intern Med. Published online February 4, 2013. doi:10.1001/jamainternmed.2013.2299 Regan L. Bailey, PhD, RD; Jaime J. Gahche, MPH; Paige E. Miller, PhD, RD; Paul R. Thomas, PhD, RD; Johanna T. Dwyer, PhD, RD&lt;/p>
&lt;p>&lt;strong>PDF is attached at the bottom of this page&lt;/strong>&lt;/p>
&lt;p>Background: Dietary supplements are used by more than half of adults, although to our knowledge, the reasons motivating use have not been previously examined in US adults using nationally representative data. The purpose of this analysis was to examine motivations for dietary supplement use, characterize the types of products used for the most commonly reported motivations, and to examine the role of physicians and health care practitioners in guiding choices about dietary supplements.&lt;/p></description></item></channel></rss>